Merck KGaA

Shifting focus to oncology, GSK recruits a cancer vet as new chief of US pharmaceuticals — adding another woman to the top ranks of biopharma
Endpoints
Mon, 08/12/19 - 10:49 am
GSK
oncology
Merck KGaA
Maya Martinez-Davis
Tackling the remaining challenges of multiple sclerosis
Pharmaforum
Sat, 08/10/19 - 01:52 pm
Merck KGaA
MS
multiple sclerosis
evobrutinib
Startup offering free DNA sequencing signs first pharma sponsor
Stat
Tue, 06/11/19 - 09:37 am
Nebula Genomics
DNA sequencing
EMD Serono
Merck KGaA
Merck and Pfizer’s Bavencio approved for renal cell carcinoma
Pharmaforum
Wed, 05/15/19 - 10:35 am
Merck KGaA
Pfizer
Bavencio
FDA
Inlyta
advanced renal cell carcinoma
Merck KGaA retools F-star pact, walks away from lead PD-L1 drug
Fierce Biotech
Tue, 05/14/19 - 11:36 pm
Merck KGaA
bispecific antibodies
f-star
drug discovery
German Merck finally gets yes for MS drug Mavenclad
Biopharma Dive
Tue, 04/2/19 - 04:20 pm
FDA
Merck KGaA
Mavenclad
MS
multiple sclerosis
Still hunting a blockbuster, Merck KGaA scores a win in the FDA approval column — more than 13 years in the making
Endpoints
Sun, 03/31/19 - 03:53 pm
FDA
Merck KGaA
cladribine
MA
multiple sclerosis
Merck KGaA injecting €150M into biologics site where it makes immunotherapies
Fierce Pharma
Thu, 03/28/19 - 08:00 pm
Merck KGaA
Switzerland
drug manufacturing
biologics
Merck KGaA investing €1B at headquarters site as part of 5-year work agreement
Fierce Pharma
Wed, 03/20/19 - 08:07 pm
Merck KGaA
headquarters
Germany
Pfizer, Merck KGaA throw in the towel on another Bavencio PhIII as once bright hopes shrivel fast
Endpoints
Tue, 03/19/19 - 08:22 pm
Pfizer
Merck KGaA
ovarian cancer
Bavencio
Merck KGaA signs another AI deal
Pharmaforum
Fri, 03/15/19 - 09:19 am
Merck KGaA
artificial intelligence
Iktos
drug discovery
Merck KGaA admits to ‘challenging’ 2018, as currencies hit sales
Pharmaforum
Thu, 03/7/19 - 10:03 am
Merck KGaA
earnings
After Tesaro buy, GSK wades deeper into cancer unveiling big immunotherapy deal with Germany's Merck
Endpoints
Tue, 02/5/19 - 09:52 am
GSK
Merck KGaA
Tesaro
immunotherapy
Forget the suggestion box. Merck KGaA puts employee ideas on a TED stage
Fierce Pharma
Mon, 02/4/19 - 11:38 am
Merck KGaA
pharma employees
TED talks
Merck KGaA signs China digital health deal with Tencent
Pharmaforum
Thu, 01/24/19 - 11:45 am
Merck KGaA
Tencent
China
digital healthcare
artificial intelligence
Vertex sharpens focus on gene-editing in licensing deal with Merck KGaA
Endpoints
Thu, 01/24/19 - 11:39 am
Vertex Pharmaceuticals
Merck KGaA
gene editing
M9831
Bavencio fails second ovarian cancer Phase III trial
BioCentury
Fri, 12/21/18 - 11:07 pm
Merck KGaA
Bavencio
ovarian cancer
Merck KGaA hands off its CAR-T R&D operations to Intrexon in $175M deal
Endpoints
Thu, 12/20/18 - 11:50 am
Merck KGaA
CAR-T
Intrexion
M&A
Merck's Keytruda puts heat on Pfizer, Merck KGaA's Bavencio with new Merkel cell OK
Fierce Pharma
Thu, 12/20/18 - 10:12 am
Merck
Keytruda
Pfizer
Merck KGaA
Bavencio
Merkel cell carcinoma
Merck KGaA links with AI firm to iron out side-effects during R&D
Pharmaforum
Mon, 12/10/18 - 09:56 am
Merck KGaA
R&D
artificial intelligence
Cyclica
drug development

Pages